It has been demonstrated that the serum levels of RBP4 are elevated in patients with ovarian cancer, and the expression of RBP4 is increased by approximately four-fold in ovarian cancer tissues compared with its expression in the benign ovarian tissues [18,25]. The gene discussed is RBP4; the disease is ovarian carcinoma.